DONALD J. KELLERMAN - 15 Oct 2021 Form 4 Insider Report for Zosano Pharma Corp

Role
VP, Clinical Dev & Med Affairs
Signature
/s/ Steven Lo, Attorney-in-Fact for Donald J. Kellerman
Issuer symbol
N/A
Transactions as of
15 Oct 2021
Net transactions value
$0
Form type
4
Filing time
19 Oct 2021, 21:36:08 UTC
Previous filing
07 Jun 2021
Next filing
01 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZSAN Common Stock Award $0 +10,000 +20% $0.000000 60,337 15 Oct 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZSAN Stock Option (Right to Buy) Award $0 +20,000 $0.000000 20,000 15 Oct 2021 Common Stock 20,000 $0.6342 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the completion of performance vesting.
F2 Includes 10,000 RSUs which are subject to performance vesting.
F3 The shares subject to the stock option vest and become exercisable in accordance with a performance vesting schedule.